Trademarkia Logo

Australia

AU$
Trademark Search
DORATIQ

View On IPO.GOV.AU

DORATIQ
Cancelled: Cancelled at the request of IB

Last updated on 30 Jun 2022

Owner Info

EYEPOINT PHARMACEUTICALS US, INC.

480 PLEASANT STREET, SUITE B300

WATERTOWN MA 02472, UNITED STATES OF AMERICA

Serial Number

1943886 filed on 10 May 2018

Correspondent

Kimberly A. Jarman, Associate General Counsel, EyePoint Pharmaceuticals, Inc.

480 Pleasant Street, Suite A210,

Watertown MA 02472,

UNITED STATES OF AMERICA

DORATIQ

Classification Information

Class [005]
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, inc Read More

Class [010]
Sustained drug delivery systems for pharmaceuticals

Mark Details

Serial Number

1943886

Registered On

10 May 2018

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

14 Nov 2017

Mark Type

US

Legal History

Show more

Status DateAction Taken
30th Jun 2022International Registration - Correction Received
8th Jan 2022Status change to Voided
3rd Dec 2020Amendment to International Registration Contact Requested
25th Mar 2019IP Right Registration Published
25th Mar 2019International Registration in Australia Protected correspondence sent
25th Mar 2019Status change to Registered/Protected
17th Jan 2019Application Accepted correspondence sent
17th Jan 2019IP Right Acceptance Published
17th Jan 2019IP Right has been Examined
17th Jan 2019Status change to Accepted